CN112323176A - Antiviral and antibacterial spandex fiber and application thereof - Google Patents
Antiviral and antibacterial spandex fiber and application thereof Download PDFInfo
- Publication number
- CN112323176A CN112323176A CN202010998047.7A CN202010998047A CN112323176A CN 112323176 A CN112323176 A CN 112323176A CN 202010998047 A CN202010998047 A CN 202010998047A CN 112323176 A CN112323176 A CN 112323176A
- Authority
- CN
- China
- Prior art keywords
- antiviral
- antibacterial
- spandex fiber
- compound
- spandex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 90
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 74
- 229920002334 Spandex Polymers 0.000 title claims abstract description 72
- 239000004759 spandex Substances 0.000 title claims abstract description 72
- 239000000835 fiber Substances 0.000 title claims abstract description 60
- 239000003094 microcapsule Substances 0.000 claims abstract description 41
- 150000001875 compounds Chemical class 0.000 claims abstract description 33
- 239000000463 material Substances 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000004753 textile Substances 0.000 claims abstract description 9
- 239000004744 fabric Substances 0.000 claims abstract description 6
- 239000002649 leather substitute Substances 0.000 claims abstract description 4
- 239000012567 medical material Substances 0.000 claims abstract description 4
- 230000001681 protective effect Effects 0.000 claims abstract description 4
- 239000011259 mixed solution Substances 0.000 claims description 24
- 238000009987 spinning Methods 0.000 claims description 24
- -1 substituent pyrimidine compound Chemical class 0.000 claims description 22
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 16
- DNKGZSOYWMQDTK-UHFFFAOYSA-N 3-iodoprop-1-ynyl N-butylcarbamate Chemical compound CCCCNC(=O)OC#CCI DNKGZSOYWMQDTK-UHFFFAOYSA-N 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical compound ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 8
- 229960002026 pyrithione Drugs 0.000 claims description 7
- 230000000845 anti-microbial effect Effects 0.000 claims description 4
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 claims description 3
- GAZOQRUEIUBTNF-UHFFFAOYSA-N 1-[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea Chemical class N1C(=O)NC(=O)C1(CO)NC(=O)NCNC(=O)NC1(CO)NC(=O)NC1=O GAZOQRUEIUBTNF-UHFFFAOYSA-N 0.000 claims description 3
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 3
- 229940123208 Biguanide Drugs 0.000 claims description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 3
- 239000004599 antimicrobial Substances 0.000 claims description 3
- 150000001556 benzimidazoles Chemical class 0.000 claims description 3
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 3
- 230000001877 deodorizing effect Effects 0.000 claims description 3
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 150000004040 pyrrolidinones Chemical class 0.000 claims description 3
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 3
- 150000004867 thiadiazoles Chemical class 0.000 claims description 3
- 150000003577 thiophenes Chemical class 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 230000002155 anti-virotic effect Effects 0.000 abstract description 12
- 238000001914 filtration Methods 0.000 abstract description 9
- 239000004745 nonwoven fabric Substances 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 230000002045 lasting effect Effects 0.000 abstract description 2
- 230000001815 facial effect Effects 0.000 abstract 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000012071 phase Substances 0.000 description 12
- 239000002775 capsule Substances 0.000 description 11
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 239000000178 monomer Substances 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920000768 polyamine Polymers 0.000 description 3
- 239000005056 polyisocyanate Substances 0.000 description 3
- 229920001228 polyisocyanate Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 230000001442 anti-mosquito Effects 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- QXRRAZIZHCWBQY-UHFFFAOYSA-N 1,1-bis(isocyanatomethyl)cyclohexane Chemical compound O=C=NCC1(CN=C=O)CCCCC1 QXRRAZIZHCWBQY-UHFFFAOYSA-N 0.000 description 1
- ZXHZWRZAWJVPIC-UHFFFAOYSA-N 1,2-diisocyanatonaphthalene Chemical compound C1=CC=CC2=C(N=C=O)C(N=C=O)=CC=C21 ZXHZWRZAWJVPIC-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- VGHSXKTVMPXHNG-UHFFFAOYSA-N 1,3-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC(N=C=O)=C1 VGHSXKTVMPXHNG-UHFFFAOYSA-N 0.000 description 1
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- CDMDQYCEEKCBGR-UHFFFAOYSA-N 1,4-diisocyanatocyclohexane Chemical compound O=C=NC1CCC(N=C=O)CC1 CDMDQYCEEKCBGR-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- ICLCCFKUSALICQ-UHFFFAOYSA-N 1-isocyanato-4-(4-isocyanato-3-methylphenyl)-2-methylbenzene Chemical compound C1=C(N=C=O)C(C)=CC(C=2C=C(C)C(N=C=O)=CC=2)=C1 ICLCCFKUSALICQ-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- ABWDWYZSKJSXRD-UHFFFAOYSA-N N=C=O.N=C=O.C1CC=CC1 Chemical compound N=C=O.N=C=O.C1CC=CC1 ABWDWYZSKJSXRD-UHFFFAOYSA-N 0.000 description 1
- HDONYZHVZVCMLR-UHFFFAOYSA-N N=C=O.N=C=O.CC1CCCCC1 Chemical compound N=C=O.N=C=O.CC1CCCCC1 HDONYZHVZVCMLR-UHFFFAOYSA-N 0.000 description 1
- IRZPIVLJFASEKB-UHFFFAOYSA-N O=C(C1=CC(C(Cl)=O)=CC(COC(Cl)=O)=C1)Cl Chemical compound O=C(C1=CC(C(Cl)=O)=CC(COC(Cl)=O)=C1)Cl IRZPIVLJFASEKB-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- JGCWKVKYRNXTMD-UHFFFAOYSA-N bicyclo[2.2.1]heptane;isocyanic acid Chemical compound N=C=O.N=C=O.C1CC2CCC1C2 JGCWKVKYRNXTMD-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- BCXWMIMRDMIJGL-UHFFFAOYSA-N naphthalene-1,5-disulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1S(Cl)(=O)=O BCXWMIMRDMIJGL-UHFFFAOYSA-N 0.000 description 1
- FJKUZZHKEDNPDN-UHFFFAOYSA-N naphthalene-2,7-disulfonyl chloride Chemical compound C1=CC(S(Cl)(=O)=O)=CC2=CC(S(=O)(=O)Cl)=CC=C21 FJKUZZHKEDNPDN-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000909 polytetrahydrofuran Polymers 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
- D01F6/94—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of other polycondensation products
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
- D01F1/103—Agents inhibiting growth of microorganisms
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Textile Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Artificial Filaments (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
The invention discloses an antiviral and antibacterial spandex fiber, which comprises a spandex fiber and an antiviral and antibacterial compound, wherein the antiviral and antibacterial compound can be prepared into microcapsules and can be well combined with spandex, the antiviral and antibacterial spandex fiber has higher antiviral and antibacterial properties, and the antiviral and antibacterial spandex fiber has the advantages of simple and convenient process, controllable cost, excellent performance, extremely high market value and lasting antiviral and antibacterial effects when in use. The anti-virus and anti-bacterial spandex fiber can be applied to fabrics, textiles, sanitary products, medical materials, filtering materials, masks, head covers, protective clothing, clothes, shoes and socks, synthetic leather, facial masks, bedding, towels, socks, carpets, household textiles, air filtering materials, non-woven fabric products, sanitary towels, wet tissues, diapers and protection pad products.
Description
Technical Field
The invention relates to the technical field of antiviral and antibacterial fibers, in particular to an antiviral and antibacterial spandex fiber and application thereof
Background
In order to endow the surface of spandex fibers with special properties such as antibiosis, antivirus and the like, antiviral and antibacterial compounds with corresponding functions can be added, however, the technology of the antiviral and antibacterial spandex fibers on the market is complicated at present, and the cost is increased, for example, Chinese patent CN200610098003.9 discloses an anti-mosquito fabric, which uses an anti-mosquito microcapsule and adhesive polyacrylate to jointly treat the fabric. In addition, the functional components of the existing anti-viral and anti-bacterial spandex fibers cannot continuously play a role for a long time.
Disclosure of Invention
In order to solve the above problems, a first aspect of the present invention provides an antiviral and antibacterial spandex fiber comprising a spandex fiber and an antiviral and antibacterial compound.
Preferably, the antiviral and antibacterial compound is at least one selected from the group consisting of a substituted pyrimidine compound, a substituted pyridine compound, a substituted pyrrole compound, a substituted isothiazolinone, a substituted imidazoline compound, a benzisothiazolinone compound, a biguanide compound, a monoguanidine compound, a benzoxazole derivative, a benzothiazole derivative, a thiadiazole derivative, a benzimidazole derivative, a thiophene derivative, a quinoline derivative, a pyrrolidone derivative, an imidazolidinyl urea derivative, 1-hydroxy-2-pyridinethione, 2- (4 ' -thiazolyl) benzimidazole, 2, 4, 4 ' -trichloro-2 ' -hydroxydiphenyl ether, trichlorocarban and 3-iodopropynyl butyl carbamate.
Preferably, the antiviral and antibacterial compound is a mixture of 1-hydroxy-2-pyridinethione, 2- (4' -thiazolyl) benzimidazole, and 3-iodopropynyl butyl carbamate.
Preferably, the antiviral and antibacterial compound is prepared into a microcapsule shape.
Preferably, the microcapsules are nano-sized microcapsules.
The second aspect of the invention provides a preparation method of an antiviral and antibacterial spandex fiber, which at least comprises the following steps:
(1) adding an antiviral and antibacterial compound into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
Preferably, the preparation method of the anti-virus and anti-bacterial spandex fiber at least comprises the following steps:
(1) adding microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
Preferably, the preparation method of the anti-virus and anti-bacterial spandex fiber at least comprises the following steps:
(1) adding the nano-scale microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
In a third aspect, the invention provides an application of the anti-virus and anti-bacterial spandex fiber, which is applied to fabrics, textiles, sanitary products, medical materials, filtering materials, masks, head covers, protective clothing, clothes, shoes and socks, synthetic leather, masks, bedding, towels, socks, carpets, household textiles, air filtering materials, non-woven fabric products, sanitary towels, wet tissues, diapers and pad products.
Preferably, the application of the anti-virus and anti-bacterial spandex fiber is applied to an anti-microbial deodorizing product.
Has the advantages that: the invention provides an antiviral and antibacterial spandex fiber which has higher antiviral and antibacterial properties, is simple and convenient in process, controllable in cost, excellent in performance, extremely high in market value and has a lasting antiviral and antibacterial effect.
Detailed Description
The disclosure may be understood more readily by reference to the following detailed description of preferred embodiments of the invention and the examples included therein. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present specification, including definitions, will control.
The term "prepared from …" as used herein is synonymous with "comprising". The terms "comprises," "comprising," "includes," "including," "has," "having," "contains," "containing," or any other variation thereof, as used herein, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.
The conjunction "consisting of …" excludes any unspecified elements, steps or components. If used in a claim, the phrase is intended to claim as closed, meaning that it does not contain materials other than those described, except for the conventional impurities associated therewith. When the phrase "consisting of …" appears in a clause of the subject matter of the claims rather than immediately after the subject matter, it defines only the elements described in the clause; other elements are not excluded from the claims as a whole.
When an amount, concentration, or other value or parameter is expressed as a range, preferred range, or as a range of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. For example, when a range of "1 to 5" is disclosed, the described range should be interpreted to include the ranges "1 to 4", "1 to 3", "1 to 2 and 4 to 5", "1 to 3 and 5", and the like. When a range of values is described herein, unless otherwise stated, the range is intended to include the endpoints thereof and all integers and fractions within the range.
The singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. "optional" or "any" means that the subsequently described event or events may or may not occur, and that the description includes instances where the event occurs and instances where it does not.
Approximating language, as used herein throughout the specification and claims, is intended to modify a quantity, such that the invention is not limited to the specific quantity, but includes portions that are literally received for modification without substantial change in the basic function to which the invention is related. Accordingly, the use of "about" to modify a numerical value means that the invention is not limited to the precise value. In some instances, the approximating language may correspond to the precision of an instrument for measuring the value. In the present description and claims, range limitations may be combined and/or interchanged, including all sub-ranges contained therein if not otherwise stated.
In addition, the indefinite articles "a" and "an" preceding an element or component of the invention are not intended to limit the number requirement (i.e., the number of occurrences) of the element or component. Thus, "a" or "an" should be read to include one or at least one, and the singular form of an element or component also includes the plural unless the stated number clearly indicates that the singular form is intended.
The present invention is illustrated by the following specific embodiments, but is not limited to the specific examples given below.
In order to solve the above problems, a first aspect of the present invention provides an antiviral and antibacterial spandex fiber comprising a spandex fiber and an antiviral and antibacterial compound.
In some preferred embodiments, the antiviral and antibacterial compound is at least one selected from the group consisting of a substituent pyrimidine compound, a substituent pyridine compound, a substituent pyrrole compound, a substituent isothiazolinone, a substituent imidazoline compound, a benzisothiazolinone compound, a biguanide compound, a monoguanidine compound, a benzoxazole derivative, a benzothiazole derivative, a thiadiazole derivative, a benzimidazole derivative, a thiophene derivative, a quinoline derivative, a pyrrolidone derivative, an imidazolidinyl urea derivative, 1-hydroxy-2-pyridinethione, 2- (4 ' -thiazolyl) benzimidazole, 2, 4, 4 ' -trichloro-2 ' -hydroxydiphenyl ether, trichlorocarban and 3-iodopropynyl butyl carbamate.
In some preferred embodiments, the antiviral and antibacterial compound is a mixture of 1-hydroxy-2-pyridinethione, 2- (4' -thiazolyl) benzimidazole, and butyl 3-iodopropynyl carbamate.
In some preferred embodiments, the antiviral and antibacterial compound is formulated into a microcapsule.
The term "microcapsule" as used herein refers to a micro-container or package having a polymeric or inorganic wall.
In some preferred embodiments, the microcapsules comprise a wall and a core, the core being prepared from an antiviral or antibacterial compound.
In some preferred embodiments, the wall comprises a compound resulting from the copolymerization of a reactive monomer comprising a vinyl group.
In some preferred embodiments, the vinyl-containing reactive monomer is selected from one or more of olefins, alkenyl carboxylic acids, alkenyl carboxylates, alkenyl aromatics, alkenyl heterocycles, alkenyl amides.
In other preferred embodiments, the polymer is obtained by polycondensation of reactive monomers; the reactive monomer is selected from at least two of polyisocyanate, polyol, formaldehyde, urea, polyamine, polyacyl chloride and polyphenol.
The terms "polyisocyanate", "polyol", "polyamine", "polyacyl chloride", "polyphenol" herein refer to a functional compound having a functionality of at least 2 with respect to the corresponding functional group.
Examples of the polyisocyanate include 1, 3-cyclopentane diisocyanate, 1, 3-cyclopentene diisocyanate, 1, 4-cyclohexane diisocyanate, 1, 3-cyclohexane diisocyanate, isophorone diisocyanate (IPDI)), methylenebis (cyclohexyl isocyanate) (H12MDI), methylcyclohexane diisocyanate, norbornane diisocyanate (NBDI), bis (isocyanatomethyl) cyclohexane (H6XDI), toluene Diisocyanate (TDI), m-phenylene diisocyanate, p-phenylene diisocyanate, 4 ' -diphenyl diisocyanate, 1, 5-Naphthalene Diisocyanate (NDI), diphenylmethane diisocyanate (MDI), 4 ' -toluidine diisocyanate (TODI), 4 ' -diphenyl ether diisocyanate, Hexamethylene Diisocyanate (HDI), and polymers thereof.
Examples of the polyhydric alcohol include polyethylene glycol, polypropylene glycol, and polytetrahydrofuran.
Examples of the polyamine include hexamethylenetetramine, propyleneglycol bis- (4, 4 ' -diamino) benzoate, 3 ' -dichloro-4, 4 ' -diaminodiphenylmethane, phenylenediamine, diethylenetriamine, triethylenetetramine, and the like.
Examples of the polybasic acid chlorides include benzenepolycarboxylic acid chloride, 1, 5-naphthalenedisulfonyl chloride, 1, 3, 6-naphthalenedisulfonyl chloride, and 5-chlorocarbonyloxymethylisophthaloyl chloride.
Examples of the polyhydric phenol include hydroquinone, resorcinol, and catechol.
In some preferred embodiments, the capsule wall is selected from one of polyurethane, epoxy, polyacrylate, silicone polyacrylate.
In some preferred embodiments, the polyacrylate is a polyacrylate containing a heterocyclic structure, and the preparation monomers are a (meth) acrylate monomer and a heterocyclic compound monomer containing a vinyl group.
The preparation method of the microcapsule of the present invention is any one of those well known to those skilled in the art, such as in situ polymerization method and interfacial polymerization method.
The inventor finds in careful study that the capsule wall made of specific materials can generate interaction between microcapsules and between the microcapsules and a base material, ensure the long-lasting function of the microcapsules and can be firmly attached to various surfaces.
In some preferred embodiments, the microcapsules are nanoscale microcapsules.
The second aspect of the invention provides a preparation method of an antiviral and antibacterial spandex fiber, which at least comprises the following steps:
(1) adding an antiviral and antibacterial compound into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
In some preferred embodiments, the preparation method of the antiviral and antibacterial spandex fiber at least comprises the following steps:
(1) adding microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
In some preferred embodiments, the preparation method of the antiviral and antibacterial spandex fiber at least comprises the following steps:
(1) adding the nano-scale microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
In a third aspect, the invention provides an application of the anti-virus and anti-bacterial spandex fiber, which is applied to fabrics, textiles, sanitary products, medical materials, filtering materials, masks, head covers, protective clothing, clothes, shoes and socks, synthetic leather, masks, bedding, towels, socks, carpets, household textiles, air filtering materials, non-woven fabric products, sanitary towels, wet tissues, diapers and pad products.
In some preferred embodiments, the antiviral and antibacterial spandex fiber is applied to an antimicrobial deodorizing product.
Examples
The present invention will be specifically described below by way of examples. It should be noted that the following examples are only for illustrating the present invention and should not be construed as limiting the scope of the present invention, and that the insubstantial modifications and adaptations of the present invention by those skilled in the art based on the above disclosure are still within the scope of the present invention.
Example 1
The embodiment provides an antiviral and antibacterial spandex fiber, which comprises a spandex fiber and an antiviral and antibacterial compound, wherein the antiviral and antibacterial compound is a capsule core of a microcapsule, the microcapsule further comprises a capsule wall, the capsule wall is polyurethane, and the antiviral and antibacterial compound is a mixture of 1-hydroxy-2-pyrithione, 2- (4' -thiazolyl) benzimidazole and 3-iodopropynyl butyl carbamate. The CAS number of the 1-hydroxy-2-pyrithione is as follows: 1121-31-9, the CAS number of the 2- (4' -thiazolyl) benzimidazole is: 148-79-8, the CAS number of the 3-iodopropynyl butyl carbamate is: 55406-53-6.
The preparation method of the microcapsule comprises the following steps:
mixing isophorone diisocyanate (IPDI)), 1-hydroxy-2-pyridinethione, 2- (4' -thiazolyl) benzimidazole, 3-iodopropynyl butyl carbamate and cyclohexane to form an oil phase, wherein the weight ratio of the five components is 6: 1: 2: 3: 40; polyethylene glycol with the number average molecular weight of 800 is dissolved in 1 wt% of sodium hydroxide aqueous solution to serve as an aqueous phase, and the weight ratio of the polyethylene glycol to the sodium hydroxide aqueous solution is 1: 20; heating the water phase to 50 ℃, dropping 40mL of the oil phase into 30mL of the water phase under the stirring condition, reacting for 2h after the dropping is finished, filtering to obtain microcapsule emulsion, and removing the solvent to obtain the microcapsule.
The embodiment also provides a preparation method of the anti-virus and anti-bacterial spandex fiber, which comprises the following steps:
(1) adding microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
Example 2
The embodiment provides an antiviral and antibacterial spandex fiber, which comprises a spandex fiber and an antiviral and antibacterial compound, wherein the antiviral and antibacterial compound is a capsule core of a microcapsule, the microcapsule further comprises a capsule wall, the capsule wall is polyurethane, and the antiviral and antibacterial compound is a mixture of 1-hydroxy-2-pyrithione, 2- (4' -thiazolyl) benzimidazole and 3-iodopropynyl butyl carbamate. The CAS number of the 1-hydroxy-2-pyrithione is as follows: 1121-31-9, the CAS number of the 2- (4' -thiazolyl) benzimidazole is: 148-79-8, the CAS number of the 3-iodopropynyl butyl carbamate is: 55406-53-6.
The preparation method of the microcapsule comprises the following steps:
mixing isophorone diisocyanate (IPDI)), 1-hydroxy-2-pyridinethione, 2- (4' -thiazolyl) benzimidazole, 3-iodopropynyl butyl carbamate and cyclohexane to form an oil phase, wherein the weight ratio of the five components is 6: 1: 3: 4: 40; polyethylene glycol with the number average molecular weight of 800 is dissolved in 1 wt% of sodium hydroxide aqueous solution to serve as an aqueous phase, and the weight ratio of the polyethylene glycol to the sodium hydroxide aqueous solution is 1: 20; heating the water phase to 50 ℃, dropping 40mL of the oil phase into 30mL of the water phase under the stirring condition, reacting for 2h after the dropping is finished, filtering to obtain microcapsule emulsion, and removing the solvent to obtain the microcapsule.
The embodiment also provides a preparation method of the anti-virus and anti-bacterial spandex fiber, which comprises the following steps:
(1) adding microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
Example 3
The embodiment provides an antiviral and antibacterial spandex fiber, which comprises a spandex fiber and an antiviral and antibacterial compound, wherein the antiviral and antibacterial compound is a capsule core of a microcapsule, the microcapsule further comprises a capsule wall, the capsule wall is polyurethane, and the antiviral and antibacterial compound is a mixture of 1-hydroxy-2-pyrithione, 2- (4' -thiazolyl) benzimidazole and 3-iodopropynyl butyl carbamate. The CAS number of the 1-hydroxy-2-pyrithione is as follows: 1121-31-9, the CAS number of the 2- (4' -thiazolyl) benzimidazole is: 148-79-8, the CAS number of the 3-iodopropynyl butyl carbamate is: 55406-53-6.
The preparation method of the microcapsule comprises the following steps:
mixing isophorone diisocyanate (IPDI)), 1-hydroxy-2-pyridinethione, 2- (4 '-thiazolyl) benzimidazole, 3-iodopropynyl butyl carbamate and cyclohexane to form an oil phase, wherein the weight ratio of the isophorone diisocyanate to the 1-hydroxy-2-pyridinethione to the 2- (4' -thiazolyl) benzimidazole to the 3-iodopropynyl butyl carbamate to the cyclohexane is 6: 1: 3: 5: 40; polyethylene glycol with the number average molecular weight of 800 is dissolved in 1 wt% of sodium hydroxide aqueous solution to serve as an aqueous phase, and the weight ratio of the polyethylene glycol to the sodium hydroxide aqueous solution is 1: 20; heating the water phase to 50 ℃, dropping 40mL of the oil phase into 30mL of the water phase under the stirring condition, reacting for 2h after the dropping is finished, filtering to obtain microcapsule emulsion, and removing the solvent to obtain the microcapsule.
The embodiment also provides a preparation method of the anti-virus and anti-bacterial spandex fiber, which comprises the following steps:
(1) adding microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
Evaluation of Performance
The antimicrobial nonwoven fabrics obtained in examples 1 to 3 were subjected to persistent antibacterial test, and according to GB/T20944.1-2007 evaluation part 1 of antibacterial performance of textiles: the method described in agar plate diffusion method "comprises testing a sample and a control sample, cutting the sample into round samples with diameter of 25mm, placing the test bacteria such as Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli on a culture medium, culturing at 37 + -2 deg.C for 7d, observing the antibacterial band, and evaluating, wherein the evaluation standard of antibacterial effect is shown in Table 1, and the test result is shown in Table 2.
TABLE 1 evaluation of antibacterial Effect
TABLE 2
The embodiments 1 to 3 show that the anti-virus and anti-bacterial spandex fiber provided by the invention can keep the anti-virus and anti-bacterial characteristics for a long time, has lower production cost and higher product applicability, and has wide market prospect.
The foregoing examples are merely illustrative and serve to explain some of the features of the method of the present invention. The appended claims are intended to claim as broad a scope as is contemplated, and the examples presented herein are merely illustrative of selected implementations in accordance with all possible combinations of examples. Accordingly, it is applicants' intention that the appended claims are not to be limited by the choice of examples illustrating features of the invention. Also, where numerical ranges are used in the claims, subranges therein are included, and variations in these ranges are also to be construed as possible being covered by the appended claims.
Claims (10)
1. An antiviral and antibacterial spandex fiber is characterized by comprising a spandex fiber and an antiviral and antibacterial compound.
2. The anti-viral and anti-bacterial spandex fiber according to claim 1, the antiviral and antibacterial compound is at least one selected from the group consisting of a substituent pyrimidine compound, a substituent pyridine compound, a substituent pyrrole compound, a substituent isothiazolinone, a substituent imidazoline compound, a benzisothiazolinone compound, a biguanide compound, a monoguanidine compound, a benzoxazole derivative, a benzothiazole derivative, a thiadiazole derivative, a benzimidazole derivative, a thiophene derivative, a quinoline derivative, a pyrrolidone derivative, an imidazolidinyl urea derivative, 1-hydroxy-2-pyridinethione, 2- (4 ' -thiazolyl) benzimidazole, 2, 4, 4 ' -trichloro-2 ' -hydroxydiphenyl ether, trichlorocarban and 3-iodopropynyl butyl carbamate.
3. The anti-viral and anti-bacterial spandex fiber according to claim 2, wherein the anti-viral and anti-bacterial compound is a mixture of 1-hydroxy-2-pyrithione, 2- (4' -thiazolyl) benzimidazole, 3-iodopropynyl butyl carbamate.
4. The anti-viral and antibacterial spandex fiber according to any one of claims 1 to 3, characterized in that the anti-viral and antibacterial compound is prepared in the form of microcapsules.
5. The anti-viral and antibacterial spandex fiber according to claim 4, wherein the microcapsules are nano-microcapsules.
6. A method for preparing the antiviral and antibacterial spandex fiber according to any one of claims 1 to 3, characterized by comprising at least the following steps:
(1) adding an antiviral and antibacterial compound into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
7. The preparation method of the antiviral and antibacterial spandex fiber according to claim 4, characterized by comprising at least the following steps:
(1) adding microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
8. The preparation method of the antiviral and antibacterial spandex fiber according to claim 5, characterized by comprising at least the following steps:
(1) adding the nano-scale microcapsules into a spandex spinning solution, and stirring to obtain a mixed solution A;
(2) and (3) carrying out spinning, drafting, oiling and forming on the mixed solution A to obtain the antiviral and antibacterial spandex fiber.
9. Use of the antiviral and antibacterial spandex fiber according to any one of claims 1 to 5, characterized in that it is applied to fabrics, textiles, hygiene products, medical materials, filter materials, masks, head covers, protective clothing, apparel, footwear, synthetic leather, face masks, bedding, towels, socks, carpets, home textiles, air filter materials, nonwoven products, sanitary napkins, wet wipes, diapers, and pad products.
10. Use of the antiviral and antibacterial spandex fiber according to any one of claims 1 to 5, in an antimicrobial deodorizing product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010998047.7A CN112323176A (en) | 2020-09-21 | 2020-09-21 | Antiviral and antibacterial spandex fiber and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010998047.7A CN112323176A (en) | 2020-09-21 | 2020-09-21 | Antiviral and antibacterial spandex fiber and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112323176A true CN112323176A (en) | 2021-02-05 |
Family
ID=74303886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010998047.7A Pending CN112323176A (en) | 2020-09-21 | 2020-09-21 | Antiviral and antibacterial spandex fiber and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112323176A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113666886A (en) * | 2021-08-26 | 2021-11-19 | 诸暨华海氨纶有限公司 | Antibacterial spandex fiber for diaper and preparation method thereof |
| CN115045006A (en) * | 2022-07-11 | 2022-09-13 | 四川大学 | Polyurethane nanofiber material for air purification and preparation method thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102618962A (en) * | 2012-03-22 | 2012-08-01 | 鲁东大学 | Antibacterial polyurethane fiber and preparation method thereof |
| CN108914238A (en) * | 2018-07-17 | 2018-11-30 | 天津工业大学 | A kind of temperature adjustment bacteriostatic fiber and preparation method thereof |
| CN111235678A (en) * | 2020-03-31 | 2020-06-05 | 王云甘 | Antibacterial and antiviral functional fiber and preparation method thereof |
| CN111286809A (en) * | 2020-04-01 | 2020-06-16 | 无锡市红博面料馆有限公司 | Antibacterial spandex fiber and preparation method thereof |
| CN111387180A (en) * | 2020-04-28 | 2020-07-10 | 连云港杜钟新奥神氨纶有限公司 | Preparation method of aromatic mosquito-repellent microcapsule and spandex |
| CN111534007A (en) * | 2020-06-24 | 2020-08-14 | 广州市中诚新型材料科技有限公司 | Compound antiviral antibacterial health-care multifunctional fiber master batch and preparation and application thereof |
| CN111534877A (en) * | 2020-06-04 | 2020-08-14 | 广州市中诚新型材料科技有限公司 | Compound Chinese medicinal multifunctional antibacterial fiber for resisting coronavirus and influenza virus |
| CN111671181A (en) * | 2020-06-04 | 2020-09-18 | 中国制浆造纸研究院有限公司 | Mask and preparation method thereof |
-
2020
- 2020-09-21 CN CN202010998047.7A patent/CN112323176A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102618962A (en) * | 2012-03-22 | 2012-08-01 | 鲁东大学 | Antibacterial polyurethane fiber and preparation method thereof |
| CN108914238A (en) * | 2018-07-17 | 2018-11-30 | 天津工业大学 | A kind of temperature adjustment bacteriostatic fiber and preparation method thereof |
| CN111235678A (en) * | 2020-03-31 | 2020-06-05 | 王云甘 | Antibacterial and antiviral functional fiber and preparation method thereof |
| CN111286809A (en) * | 2020-04-01 | 2020-06-16 | 无锡市红博面料馆有限公司 | Antibacterial spandex fiber and preparation method thereof |
| CN111387180A (en) * | 2020-04-28 | 2020-07-10 | 连云港杜钟新奥神氨纶有限公司 | Preparation method of aromatic mosquito-repellent microcapsule and spandex |
| CN111534877A (en) * | 2020-06-04 | 2020-08-14 | 广州市中诚新型材料科技有限公司 | Compound Chinese medicinal multifunctional antibacterial fiber for resisting coronavirus and influenza virus |
| CN111671181A (en) * | 2020-06-04 | 2020-09-18 | 中国制浆造纸研究院有限公司 | Mask and preparation method thereof |
| CN111534007A (en) * | 2020-06-24 | 2020-08-14 | 广州市中诚新型材料科技有限公司 | Compound antiviral antibacterial health-care multifunctional fiber master batch and preparation and application thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113666886A (en) * | 2021-08-26 | 2021-11-19 | 诸暨华海氨纶有限公司 | Antibacterial spandex fiber for diaper and preparation method thereof |
| CN115045006A (en) * | 2022-07-11 | 2022-09-13 | 四川大学 | Polyurethane nanofiber material for air purification and preparation method thereof |
| CN115045006B (en) * | 2022-07-11 | 2023-02-07 | 四川大学 | Polyurethane nanofiber material for air purification and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112323176A (en) | Antiviral and antibacterial spandex fiber and application thereof | |
| JP5645145B2 (en) | Process for producing reactive polyurethane emulsions | |
| JPH0351821B2 (en) | ||
| KR20090026765A (en) | Aqueous non-ionic hydrophilic polyurethane dispersions, and a continuous process of making the same | |
| US20100120311A1 (en) | Method for providing textiles with desensitized silver components | |
| CN102618962B (en) | Antibacterial polyurethane fiber and preparation method thereof | |
| JP2000328443A (en) | Antibacterial use of fiber having fixed tea polyphenol | |
| US7700502B2 (en) | Antimicrobial textile | |
| JP2014525481A5 (en) | ||
| CN102493014B (en) | A kind of epsilon-polylysine polyvinyl alcohol compound bio anti-bacterial fibre and preparation method thereof | |
| EP3580254A1 (en) | Polymers for hydrophobic and oelophobic textile finishing | |
| JP4099282B2 (en) | Antibacterial molded product | |
| CN108486875B (en) | Antibacterial non-woven fabric for medical care and health as well as preparation method and application thereof | |
| CN107557904B (en) | Antimicrobial fabric with nano silver particles and its production method | |
| JP2008501820A (en) | Antibacterial polymer composition | |
| CN106592230B (en) | A kind of preparation method for the antibacterial biological biocompatible fabric that high surface potential mediates | |
| JP2013185292A (en) | Antibacterial processing agent for fiber, method for producing the same and method for producing antibacterial fiber | |
| KR20170028852A (en) | A method for preparing antibacterial fiber | |
| WO2020053105A1 (en) | Lactam coated textile | |
| CN111631222A (en) | Water-insoluble compound microcapsule and application thereof | |
| JPH08296173A (en) | Antimicrobial fibers | |
| CN110965143B (en) | Fiber with antibacterial and deodorizing performance and preparation method thereof | |
| US20100124562A1 (en) | Antimicrobial composition, process for preparing the same, and utilization thereof | |
| CN111868323B (en) | Antibacterial and mildewproof fiber structure | |
| CN109505018B (en) | Antibacterial and anti-mite Tiancha fiber and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210205 |
|
| RJ01 | Rejection of invention patent application after publication |